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INTRODUCTION 
Solubility is a significant physicochemical factor 
affecting absorption of drug and its therapeutic 
effectiveness. Formulation development would lead to 
be failure if drug having poor aqueous solubility. The 
low dissolution rate and low solubility of drug 
substances in water in aqueous G.I.T fluid frequently 
leads to inadequate bioavailability. The venture to 
improve the solubility and dissolution of hydrophobic 
drugs remain one of the dificult tasks in drug 
development. Several methods have been introduced to 
triumph over this problem.
1
  
Various methods to increase the solubility of drugs are 
.available such as liquisolid, in which drug in solution 
state or dissolved drug is adsorbed over insoluble 
carriers
 2
 
To improve wettability and solubility of various 
lipophilic substances surfactants can also be used in 
formulations. 
3
 Micronization of drug is not ideal 
because micronized product has the propensity of 
agglomeration, which leads to reduced effective surface 
area for dissolution. But solid dispersion is the mainly 
promising method to formulators because of its 
simplicity of preparation, ease of optimization, and 
reproducibility
.4
 A poorly water soluble drug, more 
recently, has been defined in general terms to require 
more time to dissolve in the gastrointestinal fluid than it 
takes to be absorbed in the gastrointestinal tract. Drugs 
with low aqueous solubility have low dissolution rates 
and hence suffer from oral bioavailability problems. 
Model list of Essential Medicines of the World Health 
Organization (WHO) has assigned BCS 
(Biopharmaceutics Classification System) classification 
on the basis of data available in the public domain. Out 
of 130 orally administered drugs on the WHO list, 61 
could be classified with certainty.  
84% of these drugs belong to class I (highly soluble, 
highly permeable) 
17% to class II (poorly soluble, highly permeable)  
39% to class III (highly soluble, poorly permeable) and  
10% to class IV (poorly soluble, poorly permeable) 
The term solid dispersion refers to a group of solid 
products consisting of at least two different 
components, a hydrophilic matrix and a hydrophobic 
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drug. The drug can be dispersed molecularly, in 
amorphous particles (clusters) or in crystalline 
particles
5
. Pharmaceutical polymers are used to create 
this matrix and their selection is based on many factors, 
including physicochemical (e.g. drug–polymer 
miscibility and stability) and pharmacokinetic (e.g. rate 
of absorption) constraints
6
. Fig. 1 categorizes various 
possible categories of solid dispersions. The solid-
dispersion components consist mainly of active 
pharmaceutical ingredients (API), the polymer, 
plasticizers, stabilizers, and other agents.  
Chiou and Riegelman defined the term solid dispersion 
as 
7
 “A dispersion involving the formation of eutectic 
mixtures of drugs with water soluble carriers by melting 
of their physical mixtures” 
Solid dispersion systems can increase dissolution rate 
and bioavailability of water insoluble drugs as when 
these are exposed to aqueous media, the carrier 
dissolves, and the drug is released as very fine colloidal 
particles. This greatly reduces particle size and 
increases surface area, which results in improved 
dissolution rates and per oral absorption. Furthermore, 
no energy is required to break up the crystal lattice of a 
drug during the dissolution process. Drug solubility and 
wettability may be increased by surrounding 
hydrophilic carriers 
8-9
 This approach has been used for 
a variety of poorly soluble drugs such as nimesulide, 
ketoprofen, tenoxicam, nifedipine, nimodipine, 
ursodeoxycholic acid, carbamazepine, celecoxib and 
albendazole. Various hydrophilic carriers such as 
polyethylene glycol (PEG), polyvinylpyrrolidone 
(PVP), hydroxypropyl cellulose (HPC), 
hydroxypropylmethyl cellulose (HPMC), gums, sugar, 
mannitol, urea, hydroxypropylmethyl cellulose 
phthalate, gelucires, eudragits and chitosan have been 
investigated for improvement of dissolution 
characteristics and bioavailability of poorly aqueous 
soluble drugs 
10
 
In solid dispersions, a portion of drug dissolves 
immediately to saturate the gastrointestinal tract fluid, 
and excess drug precipitates as fine colloidal particles 
or oily globules of submicron size. The development of 
solid dispersions as a practically viable method to 
enhance bioavailability of poorly water-soluble drugs 
overcame the limitations of previous approaches such as 
salt formation, Solubilization, cosolvency, and particle 
size reduction
11
. Based on their molecular arrangement, 
six different types of solid dispersions can be 
distinguished as described in Table 1. Moreover, not the 
preparation method but the molecular arrangement 
governs the properties of solid dispersions. 
MATERIALS USED AS CARRIER FOR SOLID 
DISPERSIONS 
The selection of the carrier has the influence on the 
dissolution characteristics of the dispersed drug, since 
the dissolution rate of one component from the surface 
is affected by the other component in a multiple 
component mixture. Therefore, a water-soluble carrier 
results in a faster release of the drug from the matrix. A 
poorly soluble or insoluble carrier leads to slower 
release of a drug from the matrix.  If the active drug 
present is a minor component in the dispersion, faster 
release of a drug can be achieved from matrix
12, 13, 14
. 
Various carriers used for preparation of solid 
dispersions are tabulated in Table 2. 
 
Table 1: Materials used as carrier for solid dispersion 
S. No  Category Carriers Example 
1 Sugars Dextrose, sucrose, galactose, sorbitol, maltose, xylitol, 
mannitol, lactose 
Rofecoxib from sorbitol 
and mannitol 
2 Acids Citric acid, succinic acid Felodipine, rofecoxib from 
citric acid 
3 Polymeric 
materials 
Polyvinyl pyrrolidone(PVP), polyethylene glycol (PEG), 
hydroxypropyl methyl cellulose (HPMC), methyl 
cellulose (MC), hydroxy ethyl cellulose, cyclodextrin, 
hydroxy propyl cellulose, pectin, galactomannan 
Temazepam , felodipine, 
etoricoxib rofecoxib from 
PEG 4000 & 6000 and 
troglitazone and rofecoxib 
from PVP K30 
4 Insoluble or enteric 
polymer 
Hydroxy propyl methyl cellulose phthalate (HPMCP), 
eudragitL100, eudragit E100, eudragit RL, eudragit RS 
Indomethacin from 
eudragit E100 
5 Surfactants Polyoxyethylene stearate, poloxamer 188, deoxycholic 
acid, tweens, spans 
Felodipin and rofecoxib 
from poloxamer 188 
6 Miscellaneous Pentaerythritol, pentaerythrityl tetraacetate, urea, 
urethane, hydroxy alkyl xanthins 
Rofecoxib from urea 
 
ADVANTAGES OF SOLID DISPERSION 
The major advantage of solid dispersions is that it 
improves the dissolvability of a poorly water soluble 
drug in a pharmaceutical composition
15 
and results in 
rapid dissolution rates thereby improving the 
bioavailability of drug. Along with this, the approach 
may also offer others advantages which includes
16
 
Rapid disintegration of oral tablets  
Drug is formulated with hydrophilic carrier (e.g. PEG) 
as a solid dispersion to increase its aqueous solubility 
and dissolution. Then superdisintegrant (e.g. 
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croscarmellose sodium) is used in tablet formulation to 
achieve rapid disintegration of tablets prepared by wet 
granulation method. These rapidly disintegrating tablets 
can be used as an alternative to parenteral therapy 
enabling patient for self-medication even without the 
aid of water. 
As a formulation vehicle  
Solid dispersions can be used as formulation vehicle to 
facilitate the preclinical safety and early clinical studies 
on new chemical entities with very low aqueous 
solubility. It provides a means to rapidly assess the 
safety and efficacy profile of the drug substance that 
may be otherwise difficult to obtain. 
Particles with reduced particle size  
Solid dispersions represent the last state on particle size 
reduction, and after carrier dissolution the drug is 
molecularly dispersed in the dissolution medium. Solid 
dispersions apply this principle to drug release by 
creating a mixture of a poorly water soluble drug and 
highly soluble carriers, thus a high surface area is 
formed, resulting in an increased dissolution rate and 
consequently improved bioavailability. 
Particles with improved wettability  
Enhancement of drug solubility is related to the drug 
wettability. It was observed that even carriers without 
any surface activity, such as urea improved drug 
wettability. Carriers with surface activity, such as cholic 
acid and bile salts when used, significantly increase the 
wettability of drug. Moreover, carriers can influence the 
drug dissolution profile by direct dissolution or co-
solvent effects.  
Particles with higher porosity  
Particles in solid dispersions have been found to have a 
higher degree of porosity. Solid dispersions containing 
linear polymers produce larger and more porous 
particles than those containing reticular polymers and, 
therefore, results in a higher dissolution rate. The 
increased porosity of solid dispersion particles also 
hastens the drug release rate.  
Drugs in amorphous state  
The enhancement of drug release can usually be 
achieved if the drug in its amorphous state, because no 
energy is required to break up the crystal lattice during 
the dissolution process. In solid dispersions, drugs are 
presented as supersaturated solutions after system 
dissolution, and it is speculated that if drugs precipitate 
it is as a metastable polymorphic form with higher 
solubility than the most stable crystal form. 
Disadvantages of Solid Dispersion
17
 
1. Moreover, most of the polymers used in solid 
dispersions can absorb moisture, which may result in 
phase separation, crystal growth or conversion from the 
amorphous to the crystalline state or from a metastable 
crystalline form to a more stable structure during 
storage. This may result in decreased solubility and 
dissolution rate. 
2. Drawback of solid dispersions is their poor scale-up 
for the purposes of manufacturing. 
Categories of solid dispersion 
 
 
Fig. 1: Categories of solid dispersion 
 
METHODS OF PREPARATION OF SOLID 
DISPERSIONS 
Various methods have been developed for preparation 
of solid dispersions, these methods deal with the 
challenge of mixing a matrix and a drug, preferably on a 
molecular level, while matrix and drug are generally 
poorly miscible. During many of the preparation 
techniques, demixing (partially or complete), and 
formation of different phases is observed. Phase 
separations like crystallization or formation of 
amorphous drug clusters are difficult to control and 
therefore unwanted. Various preparative methods are 
shown in Fig. 2. 
The brief description of the methods is as follows:
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Fig. 2: Method of preparation of solid dispersions 
Solvent evaporation method 
In this method, the physical mixture of the drug and 
carrier is dissolved in a common solvent, which is 
evaporated until a clear, solvent free film is left. The 
film is further dried to constant weight. The main 
advantage of the solvent method is thermal 
decomposition of drugs or carriers can be prevented 
because of the relatively low temperatures required for 
the evaporation of organic solvents 
18
. 
However, some disadvantages are associated with this 
method such as 
1) The higher cost of preparation. 
2) The difficulty in completely removing liquid solvent. 
3) The possible adverse effect of traces of the solvent 
on the chemical stability 
4) The selection of a common volatile solvent. 
5) The difficulty of reproducing crystal form. 
6) In addition, a super saturation of the solute in the 
solid system cannot be attained except in a System 
showing highly viscous properties. 
Modified solvent evaporation method 
Drug is dissolved in organic solvent at its saturation 
solubility with continuous stirring for some time. 
Polymer is suspended in sufficient amount of water (up 
to wet mass of polymer). The drug solution is poured at 
once into polymer suspension. The entire solvent is 
evaporated. The mass obtained is dried. 
Melting /Fusion method 
This method involves the preparation of physical 
mixture of a drug and a water soluble carrier and 
heating it directly until it melted. The melted mixture is 
then solidified rapidly in an ice-bath under vigorous 
stirring. The final solid mass is crushed, pulverized and 
sieved. The modification in the method can be done by 
pouring the homogenous melt in the form of a thin layer 
onto a ferrite plate or a stainless steel plate and cooled 
by flowing air or water on the opposite side of the plate. 
In addition, a super-saturation of a solute or drug in a 
system can often be obtained by quenching the melt 
rapidly from a high temperature. Under such conditions, 
the solute molecule is arrested in the solvent matrix by 
the instantaneous solidification process. The quenching 
technique gives a much finer dispersion of crystallites 
when used for simple eutectic mixtures
19
. Advantage of 
melting method is that it is economic and solventless 
process, however this method is not suitable for the 
drug or carrier which is unstable at fusion temperature 
or evaporates at higher temperature. Some of the means 
to overcome these problems could be by heating the 
physical mixture in a sealed container or melting it 
under vacuum or in presence of inert gas like nitrogen 
to prevent oxidative degradation of drug or carrier. E.g. 
Albendazole and urea solid dispersions were prepared 
by this method
20
 
Kneading Technique 
In this method, carrier is permeated with water and 
transformed to paste. Drug is then added and kneaded 
for particular time. The kneaded mixture is then dried 
and passed through sieve if necessary. 
Co-precipitation method 
Required amount of drug is added to the solution of 
carrier. The system is kept under magnetic agitation and 
protected from the light. The formed precipitate is 
separated by vacuum filtration and dried at room 
temperature in order to avoid the loss of the structure 
water from the inclusion complex. 
Co-grinding method 
Physical mixture of drug and carrier is mixed for some 
time employing a blender at a particular speed. The 
mixture is then charged into the chamber of a vibration 
ball mill steel balls are added. The powder mixture is 
pulverized. Then the sample is collected and kept at 
room temperature in a screw capped glass vial until use. 
Ex. chlordiazepoxide and mannitol solid dispersion was 
prepared by this method.
21
 
Gel entrapment technique 
Hydroxyl propyl methyl cellulose is dissolved in 
organic solvent to form a clear and transparent gel. 
Then drug for example is dissolved in gel by sonication 
Dalvi et al                                             Journal of Drug Delivery & Therapeutics. 2015; 5(2):20-28 24 
© 2011-14, JDDT. All Rights Reserved                                                  ISSN: 2250-1177                                              CODEN (USA): JDDTAO 
for few minutes. Organic solvent is evaporated under 
vacuum. Solid dispersions are reduced in size by mortar 
and sieved.
22
 
Spray-Drying Method 
Drug is dissolved in suitable solvent and the required 
amount of carrier is dissolved in water. Solutions are 
then mixed by sonication or other suitable method to 
produce a clear solution, which is then spray dried using 
spray dryer.
23 
Electrospinning 
Electrospinning is a process in which solid fibers are 
produced from a polymeric fluid stream solution or melt 
delivered through a millimeter-scale nozzle 
24
.This 
process involves the application of a strong electrostatic 
field over a conductive capillary attaching to a reservoir 
containing a polymer solution or melt and a conductive 
collection screen. Upon increasing the electrostatic field 
strength up to but not exceeding a critical value, charge 
species accumulated on the surface of a pendant drop 
destabilize the hemispherical shape into a conical shape 
(commonly known as Taylor s cone). Beyond the 
critical value, a charged polymer jet is ejected from the 
apex of the cone (as a way of relieving the charge built-
up on the surface of the pendant drop). The ejected 
charged jet is then carried to the collection screen via 
the electrostatic force. 
The Coulombic repulsion force is responsible for the 
thinning of the charged jet during its trajectory to the 
collection screen. The thinning down of the charged jet 
is limited If the viscosity increases, the charged jet is 
dried 
25
. This technique has tremendous potential for the 
preparation of nanofibres and controlling the release of 
biomedicine, as it is simplest, the cheapest this 
technique can be utilized for the preparation of solid 
dispersions in future. 
Freeze-drying 
This process consists of dissolving the drug and carrier 
in a common solvent, which is immersed in liquid 
nitrogen until it is fully frozen. Then, the frozen 
solution is further lyophilized. Although it is concluded 
in literature that this is a promising and suitable 
technique to incorporate drug substances in stabilizing 
matrices, the technique is poorly exploited for the 
preparation of solid dispersions. An important 
advantage of freeze drying is that the drug is subjected 
to minimal thermal stress during the formation of the 
solid dispersion. However, the most important 
advantage of freeze drying is that the risk of phase 
separation is minimized as soon as the solution is 
vitrified.
26,27 
Supercritical fluid method 
Supercritical fluid methods are mostly applied with 
carbon dioxide (CO2), which is used as either a solvent 
for drug and matrix or as an anti-solvent36,37. This 
technique consists of dissolving the drug and the carrier 
in a common solvent that is introduced into a particle 
formation vessel through a nozzle, simultaneously with 
CO2. When the solution is sprayed, the solvent is 
rapidly extracted by the SCF, resulting in the 
precipitation of solid dispersion particles on the walls 
and bottom of the vessel19. The use of processes using 
SCF reduces particle 
size, residual solvent content, without any degradation 
and often results in high yield.
28,29
 
Melt Agglomeration Process 
The utility of the surfactant systems in solubilization is 
very important. Adsorption of surfactant on solid 
surface can modify their hydrophobicity, surface 
charge, and other key properties that govern interfacial 
processes such as flocculation/dispersion, floatation, 
wetting, solubilization, detergency, and enhanced oil 
recovery and corrosion inhibition. Surfactants have also 
been reported to cause solvation/plasticization, 
manifesting in reduction of melting the active 
pharmaceutical ingredients, glass transition temperature 
and the combined glass transition temperature of solid 
dispersions. Because of these unique properties, 
surfactants have attracted the attention of investigators 
for preparation of solid dispersions. 
30, 31 
Lyophilization Technique 
Lyophilization involves transfer of heat and mass to and 
from the product under preparation. This technique was 
proposed as an alternative technique to solvent 
evaporation. Lyophilization has been thought of a 
molecular mixing technique where the drug and carrier 
are co dissolved in a common solvent, frozen and 
sublimed to obtain a lyophilized molecular dispersion.
32 
Dropping method solution 
The dropping method, developed by to facilitate the 
crystallization of different chemicals, is a new 
procedure for producing round particles from melted 
solid dispersions. This technique may overcome some 
of the difficulties inherent in the other methods. For 
laboratory-scale preparation, a solid dispersion of a 
melted drug-carrier mixture is pipette and then dropped 
onto a plate, where it solidifies into round particles. The 
use of carriers that solidify at room temperature may aid 
the dropping process. The dropping method not only 
simplifies the manufacturing process, but also gives a 
higher dissolution rate. It does not use organic solvents 
and, therefore, has none of the problems associated with 
solvent evaporation. 
Melt Extrusion Method 
Solid dispersion by this method is composed of active 
ingredient and carrier, and prepare by hot-stage 
extrusion using a co-rotating twin-screw extruder. The 
concentration of drug in the dispersions is always 40% 
(w/w). Melt extrusion technique is used in the 
preparation of diverse dosage forms in the 
pharmaceutical industry e.g. sustained-release pellets.
33 
Direct capsule filling  
Direct filling of hard gelatin capsules with the liquid 
melt of solid dispersions avoids grinding-induced 
changes in the crystallinity of the drug 
34
. This molten 
dispersion forms a solid plug inside the capsule on 
cooling to room temperature, reducing cross 
contamination and operator exposure in a dust-free 
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environment, better fill weight and content uniformity 
was obtained than with the powder-fill technique. 
However, PEG was not a suitable carrier for the direct 
capsule-filling method as the water-soluble carrier 
dissolved more rapidly than the drug, resulting in drug-
rich layers formed over the surface of dissolving plugs, 
which prevented further dissolution of the drug.
34 
Solvent melting method  
Accurately weighed drug is dissolved in organic 
solvent. The solution is incorporated into the melt of 
mannitol and cooled suddenly and mass is kept in 
desiccator for complete drying. The solidified mass is 
crushed, pulverized and passed through sieve. This 
technique possesses unique advantages of both the 
fusion and solvent evaporation methods. From a 
practical standpoint, it is only limited to drugs with a 
low therapeutic dose (less than 50 mg).
35 
CHARACTERIZATION OF SOLID 
DISPERSIONS 
Several different molecular structures of the drug in the 
matrix can be encountered in solid dispersions. Several 
techniques have been available to investigate the 
molecular arrangement in solid dispersions. However, 
most effort has been put into differentiate between 
amorphous and crystalline material. Many techniques 
are available which detect the amount of crystalline 
material in the dispersion
36 
Drug -carrier miscibility 
 Hot stage microscopy 
 Differential scanning calorimetry 
 Powder X-ray diffraction 
 NMR 1H Spin lattice relaxation time 
Drug carrier interactions 
 FT-IR spectroscopy 
 Raman spectroscopy 
 Solid state NMR 
Physical Structure 
 Scanning electron microscopy 
 Surface area analysis 
 Surface properties 
 Dynamic vapor sorption 
 Inverse gas chromatography 
 Atomic force microscopy 
 Raman microscopy 
Amorphous content 
 Polarised light optical microscopy 
 Hot stage microscopy 
 Humidity stage microscopy 
 DSC (MTDSC) 
 ITC 
 Powder X-ray diffraction 
Stability 
 Humidity studies 
 Isothermal Calorimetry 
 DSC (Tg, Temperature recrystallization) 
 Dynamic vapor sorption 
 Saturated solubility studies 
Dissolution enhancement 
 Dissolution 
 Intrinsic dissolution 
 Dynamic solubility 
 Dissolution in bio-relevant media 
Powder X-ray diffraction 
Powder X-ray diffraction can be used to qualitatively 
detect material with long range order. Sharper 
diffraction peaks indicate more crystalline material.
37
 
Infrared spectroscopy (IR) 
Infrared spectroscopy (IR) can be used to detect the 
variation in the energy distribution of interactions 
between drug and matrix. Sharp vibrational bands 
indicate crystallinity. Fourier Transformed Infrared 
Spectroscopy (FTIR) was used to accurately detect 
crystallinity ranging from 1 to 99% in pure material. 
Water vapour sorption 
Water vapour sorption can be used to discriminate 
between amorphous and crystalline material when the 
hygroscopicity is different . This method requires 
accurate data on the hygroscopicity of both completely 
crystalline and completely amorphous samples.
38 
Isothermal Microcalorimetry 
Isothermal microcalorimetry measures the 
crystallization energy of amorphous material that is 
heated above its glass transition temperature (Tg) . This 
technique has some limitations. Firstly, this technique 
can only be applied if the physical stability is such that 
only during the measurement crystallization takes place. 
Secondly, it has to be assumed that all amorphous 
material crystallizes. Thirdly, in a binary mixture of two 
amorphous compounds a distinction between 
crystallization energies of drug and matrix is difficult.
39 
Dissolution calorimetry 
Dissolution calorimetry measures the energy of 
dissolution, which is dependent on the crystallinity of 
the sample . Usually, dissolution of crystalline material 
is endothermic, whereas dissolution of amorphous 
material is exothermic. 
Macroscopic techniques 
Macroscopic techniques that measure mechanical 
properties that are different amorphous and crystalline 
material can be indicative for the degree of crystallinity. 
Density measurements and Dynamic Mechanical 
Analysis (DMA) determine the modulus of elasticity for 
and viscosity and thus affected by the degree of 
crystallinity. However, also these techniques require 
knowledge about the additivity of these properties in 
intimately mixed binary solids.
40
 
Differential Scanning Calorimetry (DSC) 
Frequently used technique to detect the amount of 
crystalline material is Differential Scanning Calorimetry 
(DSC) . In DSC, samples are heated with a constant 
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heating rate and the amount of energy necessary for that 
is detected. With DSC the temperatures at which 
thermal events occur can be detected. Thermal events 
can be a glass to rubber transition, (re)crystallization, 
melting or degradation. Furthermore, the melting- and 
(re)crystallization energy can be quantified. The melting 
energy can be used to detect the amount of crystalline 
material. 
Confocal Raman Spectroscopy 
Confocal Raman Spectroscopy is used to measure the 
homogeneity of the solid mixture. It is described that a 
standard deviation in drug content smaller than10% was 
indicative of homogeneous distribution. Because of the 
pixel size of 2 μm3, uncertainty remains about the 
presence of nano-sized amorphous drug particles. 
Temperature Modulated Differential Scanning 
Calorimetry (TMDSC) 
Temperature Modulated Differential Scanning 
Calorimetry (TMDSC) can be used to assess the degree 
of mixing of an incorporated drug. Due to the 
modulation, reversible and irreversible events can be 
separated. For example, glass transitions (reversible) are 
separated from crystallization or relaxation 
(irreversible) in amorphous materials. Furthermore, the 
value of the Tg is a function of the composition of the 
homogeneously mixed solid dispersion. It has been 
shown that the sensitivity of TMDSC is higher than 
conventional DSC. Therefore this technique can be used 
to assess the amount of molecularly dispersed drug. 
And from that the fraction of drug that is dispersed as 
separate molecules is calculated
.41
 
In Vitro Dissolution Studies 
In vitro dissolution studies are done for the find out 
dissolution behavior. The in-vitro dissolution study can 
be used to demonstrate the bioavailability or 
bioequivalence of the drug product through in vitro – in 
vivo correlation (IVIVC). On the other hand if 
absorption of the drug is dissolution rate limited that 
means the drug in the gastrointestinal fluid passes freely 
through the bio-membranes at a rate higher than it 
dissolves or is released from the dosage form. The 
specifically designed in-vivo dissolution study will be 
required in solid dispersion system to access the 
absorption rate, and hence its bioavailability and to 
demonstrate the bioequivalence ultimately. There are 
some apparatus used in United States pharmacopoeia 
for dissolution testing these are following.
42 
Solubility Studies 
Solubility studies are done for the finding out the 
solubility behavior shown by the solid dispersion 
system in different types of solvent system and body 
fluids. 
MECHANISMS BEHIND IMPROVED 
DISSOLUTION  
The formulations of solid dispersions results into 
reduction in particle size, improved wettability and 
enhancement of the dispersibility of the drug, thereby 
markedly improving the dissolution rate. The suggested 
mechanism behind this tremendous increase in 
dissolution rate may include:
43
  
 Partial transformation of crystalline drug to the 
amorphous state or altering the crystalline 
morphology  
 Formation of solid solution  
 Formation of complexes  
 Intimate mixing of the drug with hydrophilic 
excipients  
 Reduction of aggregation and agglomeration  
 Improved wetting of the drug and solubilization of 
drug by the carrier at the diffusion layer. 
Commercial Solid Dispersion Products  
In spite of almost several years of research on solid 
dispersions, their commercial application is limited. 
Only a few products have been marketed so far.
 
Amongst these few are mentioned in Table 2.
44,45
 
Table 2: Commercially marketed solid dispersions 
S. No Commercial products     Polymer used  Manufacturer Company  
1 Gris-PEG® (Griseofulvin)  Polyvinylpyrrolidone (PVP)  VIP Pharma  
2 Intelence® (Etravirine)  Hypromellose, and microcrystalline cellulose  Tibotec, Yardley, PA  
3 Cesamet® (Nabilone)  Polyvinylpyrrolidone (PVP)  Valeant Pharmaceuticals, 
Costa Mesa, CA  
4 Sporanox® (Itraconazole)  Hydroxypropylmethyl cellulose (HPMC)  Janssen Pharmaceutica, 
Titusville, NJ  
5 lopinavir and ritonavir  Polyvinylpyrrolidone–vinyl acetate copolymer  Abbott Laboratories, Abbott 
Park, IL  
 
APPLICATIONS OF SOLID DISPERSION 
 Solid dispersion systems can provide numerous 
additional benefits; some of them are as follows: 
1. In improving immunosuppressive therapy in lung 
transplant patients, dry powder 
formulationconsisting of a solid dispersion (e.g. 
Cyclosporine A) for inhalation is prepared. It can 
avoid many problems like use of local anaesthesia 
and irritating solvents. 
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2. Solid dispersion formulations were demonstrated to 
accelerate the onset of action for drugs such as 
nonsteroidal anti-inflammatory drugs (NSAIDS) 
where immediacy of action is crucial in relieving 
acute pain and inflammation.  
3. Solid dispersion systems were shown to provide 
bio available oral dosage forms for anti-cancer 
drugs, which could be substituted for standard 
injections to improve patient comfort and 
compliance.  
4. Solid dispersion systems were also found to reduce 
food effect on drug absorption, thus increasing the 
convenience of drug therapy as the need for some 
drugs to be taken with food was eliminated.  
5. Solid dispersion- based dosage form allowed for 
greater drug loading per dose and improved 
stability over a soft gelatin capsule formulation 
which thereby improved the convenience of drug 
therapy by reducing the dosing regime and 
eliminating the need for refrigerated storage.  
6. Improved absorption efficiency demonstrated for 
solid dispersion systems allows for a reduction in 
the content of active agent per dose, thus 
decreasing the cost associated with these drug 
therapies.  
7. It also act as a functional carriers that offer the 
added benefit of targeting the release of highly 
soluble forms of poorly water soluble drugs to an 
optimum site for absorption.  
These benefits demonstrate the current contributions 
and future potential of solid dispersion systems toward 
improving drug therapies for a variety of important 
medical conditions whose treatment involves poorly 
water soluble drugs. 
Recent Advances & Future Aspects  
Solid dispersion has great potential both for increasing 
the bioavailability of drug and developing controlled 
release preparations. Thus, to solve bioavailability 
issues with respect to poorly water-soluble drugs, solid 
dispersion technology has grown rapidly. The dosage 
form can be developed and prepared using small 
amounts of drugs substances in early stages of the drug 
development process, the system might have an 
advantage over such other commonly used 
bioavailability enhancement techniques as 
micronization of drugs and soft gelatin encapsulation.  
CONCLUSION  
The enhancement of oral bioavailability of poorly water 
soluble drugs remains one of the most challenging 
aspects of drug development. Dissolution of drug is the 
rate determining step for oral absorption of drugs, 
which can subsequently affect the in vivo absorption of 
drug. Because of solubility problem of many drugs the 
bioavailability of these gets affected and hence 
solubility enhancement becomes necessary. Solid 
dispersions are one of the most attractive processes to 
improve drug’s poor water solubility. Various solubility 
enhancers like water-soluble carriers, co solvents, 
surfactants and superdisintegrants via solid dispersion 
approach (fusion method and solvent evaporation 
method) aids in solubility enhancement. These 
significantly help to improve the bioavailability and 
bioequivalence.
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